- Home
- LBRDP vs VCEL Comparison
LBRDP vs VCEL Comparison
Compare LBRDP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDP
- VCEL
- Stock Information
- Founded
- LBRDP N/A
- VCEL 1989
- Country
- LBRDP United States
- VCEL United States
- Employees
- LBRDP 1900
- VCEL N/A
- Industry
- LBRDP Cable & Other Pay Television Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBRDP Telecommunications
- VCEL Health Care
- Exchange
- LBRDP Nasdaq
- VCEL Nasdaq
- Market Cap
- LBRDP N/A
- VCEL 2.1B
- IPO Year
- LBRDP N/A
- VCEL 1997
- Fundamental
- Price
- LBRDP $25.12
- VCEL $40.25
- Analyst Decision
- LBRDP
- VCEL Strong Buy
- Analyst Count
- LBRDP 0
- VCEL 8
- Target Price
- LBRDP N/A
- VCEL $62.00
- AVG Volume (30 Days)
- LBRDP N/A
- VCEL 477.0K
- Earning Date
- LBRDP N/A
- VCEL 07-31-2025
- Dividend Yield
- LBRDP N/A
- VCEL N/A
- EPS Growth
- LBRDP N/A
- VCEL 521.85
- EPS
- LBRDP N/A
- VCEL 0.05
- Revenue
- LBRDP N/A
- VCEL $238,541,000.00
- Revenue This Year
- LBRDP N/A
- VCEL $23.03
- Revenue Next Year
- LBRDP N/A
- VCEL $24.52
- P/E Ratio
- LBRDP N/A
- VCEL $780.58
- Revenue Growth
- LBRDP N/A
- VCEL 14.80
- 52 Week Low
- LBRDP N/A
- VCEL $37.39
- 52 Week High
- LBRDP N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- LBRDP 66.35
- VCEL 44.06
- Support Level
- LBRDP $24.84
- VCEL $39.39
- Resistance Level
- LBRDP $25.13
- VCEL $42.61
- Average True Range (ATR)
- LBRDP 0.16
- VCEL 1.73
- MACD
- LBRDP -0.00
- VCEL -0.15
- Stochastic Oscillator
- LBRDP 82.22
- VCEL 24.16
About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.